Rhythm's $25M Series B to Satisfy Clinical Data Appetite
A $25 million Series B financing disclosed Wednesday morning will bring the total amount invested in Rhythm Pharmaceuticals Inc. to $65 million, according to Bart Henderson, founder and president of the Boston-based company.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter